XTAE
GEFR
Market cap102mUSD
Oct 09, Last price
77.40ILS
1D
0.13%
1Q
-6.30%
IPO
-91.76%
Name
Geffen Residence & Renewal Ltd
Chart & performance
P/E
—
P/S
464.83
EPS
—
Div yield, %
—
Shrs. gr., 5y
30.52%
Rev. gr., 5y
-47.94%
Revenues
685k
+422.90%
Net income
-5m
L+0.97%
CFO
-17m
L+5.32%
Dividend
Sep 30, 20156.6337 ILS/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Geffen Residence & Renewal Ltd, together with its subsidiaries, engages in the urban renewal business in Israel. The company was formerly known as Cannomed Medical Cannabis Industries Ltd and changed its name to Geffen Residence & Renewal Ltd in January 2023. Geffen Residence & Renewal Ltd was incorporated in 1999 and is based in Ashdod, Israel.
Key people
Revital Gerber Accav
Temporary Chairwoman of the Board · since 2019
Ilan Hyden
Chief Executive Officer · since 2018
Shahar Saloman
Vice President - Finance · since 2019
Internal Auditor · since 2016
Avi Ben Rubi
Director · since 2018
Guy Rosenberg
Director · since 2018
Eli Akselrod
External Director · since 2018
Orit Zahar
External Director · since 2018
Dan Danieli
Independent Director · since 2019
Valuation
Title ILS in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||